Knights of Columbus Asset Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.41M	Sell	2,629 -1,078	-29%	-$552K	0.07%	252
2026 Q1	$1.94M	Buy	3,707 +5	+0.1%	+$2.39K	0.11%	202
2025 Q4	$2.16M	Sell	3,702 -146	-4%	-$74.6K	0.12%	181
2025 Q3	$1.76M	Sell	3,848 -755	-16%	-$282K	0.1%	210
2025 Q2	$1.39M	Buy	4,603 +736	+19%	+$219K	0.08%	228
2025 Q1	$1.28M	Sell	3,867 -828	-18%	-$272K	0.09%	222
2024 Q4	$1.45M	Buy	4,695 +2,116	+82%	+$595K	0.1%	221
2024 Q3	$547K	Sell	2,579 -2,667	-51%	-$682K	0.04%	267
2024 Q2	$1.47M	Buy	5,246 +83	+2%	+$19.8K	0.1%	234
2024 Q1	$1.38M	Sell	5,163 -3,532	-41%	-$832K	0.1%	232
2023 Q4	$2.01M	Buy	8,695 +4,386	+102%	+$767K	0.13%	230
2023 Q3	$629K	Buy	4,309 +74	+2%	+$13.9K	0.06%	262
2023 Q2	$978K	Buy	4,235 +3,655	+630%	+$990K	0.09%	246
2023 Q1	$141K	Buy	+580	New	+$158K	0.01%	318

Other funds holding MDGL

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

EAM

EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Knights of Columbus Asset Advisors's MDGL Position: Q2 2026 in Review

Knights of Columbus Asset Advisors reduced its Madrigal Pharmaceuticals (MDGL) stake by 29% in Q2 2026, selling an estimated $552K and leaving 2,629 shares worth $1.41M. The position accounts for 0.07% of the portfolio, ranked #252.

Knights of Columbus Asset Advisors first reported a position in MDGL in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.16M in Q4 2025. 125 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

Knights of Columbus Asset Advisors held 2,629 shares of Madrigal Pharmaceuticals worth $1.41M as of Q2 2026.
Knights of Columbus Asset Advisors sold 1,078 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $552K.
Madrigal Pharmaceuticals made up 0.07% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #252 holding.
Knights of Columbus Asset Advisors first reported a position in Madrigal Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
Knights of Columbus Asset Advisors's Madrigal Pharmaceuticals position peaked at $2.16M in Q4 2025.
125 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.